MV1
PHOTO COMING SOON
Lyophilized powder · Box of 10 vials · For research purposes only. Not for human consumption.
RESEARCH COMPOUND
MV1GLP
GLP-1 Receptor Agonist
MV1GLP is a synthetic long-acting analogue of glucagon-like peptide-1 (GLP-1), modified for extended half-life. It is a reference compound in incretin-pathway research and in laboratory investigation of GLP-1 receptor signalling.
KEY RESEARCH AREAS
SELECT SIZE
SOLD BY THE BOX OF 10 VIALS
QUANTITY
BUY MORE, SAVE MORE
Pricing to be announced
10mg x 10 vials · 10 vials per box
Coming soon
— not yet available to order
SECURE CHECKOUT — WE ACCEPT
- Visa
- Mastercard
- American Express
- Apple Pay
- Google Pay
For research purposes only · Not for human consumption
PUBLISHED RESEARCH
Research & Studies
GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art
PUBMED · 2021 · PMID 33068776
Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide
PUBMED · 2015 · PMID 26308095
Tirzepatide as Compared with Semaglutide for the Treatment of Obesity
PUBMED · 2025 · PMID 40353578
Pharmacokinetics and Clinical Implications of Semaglutide: A New Glucagon-Like Peptide (GLP)-1 Receptor Agonist
PUBMED · 2018 · PMID 29915923
Glucagon-like peptide-1 receptor agonist use in pregnancy: a review
PUBMED · 2025 · PMID 39181497
Disclaimer. The publications above are independent third-party research hosted on PubMed and other public databases. They are provided for reference only. MedVita Wellness is not affiliated with the authors or publishers, does not endorse their conclusions, and makes no medical claims of any kind about this compound. Nothing here describes a use, benefit or outcome for any MedVita Wellness product. All products are sold strictly for laboratory and in vitro research use and are not for human or veterinary consumption.